Needle Free Injection Systems Market, By Product (Pre-Filled Needle Free Injectors and Fillable Needle Free Injectors) By Technology (Jet-Based, Spring-Based, Laser-Powered and Vibration-Based) By Medication (Liquid-Based, Powder-Based and Depot-Based) By Application (Pain Management, Vaccine Delivery, Insulin Delivery, Pediatric Injections and Others) By Usability (Re-Usable and Disposable), By Delivery Location (Intramuscular Injectors, Intradermal Injectors and Subcutaneous Injectors); And By End-User (Hospitals, Clinics & Diagnostic Centers, Home Care, Research Laboratories and Others) – Global Industry Insights, Trends and Forecast – 2018 to 2025

Created On: Jul-2018
Report ID: IR130
Format: PDF

Needle Free Injection Systems Market: Introduction

Needle-free injection system is an advanced way of injecting drugs into the patient compared to the conventional needle injection system, as needle free injections don’t penetrate into the human skin. The needle free injections market is expected to grow due to increase in incidences of chronic diseases and communicable disease which are caused due to injection of needles. Thus, the needle free injection system reduces skin bruising, bleeding, and other diseases.

Moreover, human skin is extremely immunogenic, needle free injections helps to improve immune responsiveness towards vaccines. For instance, needle free injection systems can be used for the immunizing process of influenza, typhoid, diphtheria, tetanus, pertussis hepatitis, and other mass immunizations (measles, smallpox). These factors are expected to boost the needle free injection system market. Organizations such as World Health Organization (WHO), Centre for Disease Control (CDC), and others are highly involved in the development of needle free injections for drug, which is expected to fuel the needle free injection systems market. The market of needle free injection is also anticipated to grow due to increase in usage of self- administered drugs. Thus, the rising inclination of the populous towards self-administered drugs coupled with its safety, protection towards skin bleeding and others factors, owing to which the needle free injection systems market is expected to propel during the forecast period.

Needle Free Injection Systems & its Importance:

The needle free injection system market is constantly increasing due to various factors such as growing needle injuries associated with injections, needle phobia among adults and children, and other. According to the study in Behavioral Neurology, in 2014, about 5-6% of the global population is expected to suffer from needle phobia which in turn impacts the patient’s clinic or hospital visits, due to avoidance of treatments by needle.

Needle phobia has a huge impact on the vaccination process of infants and children. According to the study printed by Clinical Journal of Pain, in 2015, 12 billion vaccinations per year globally were recorded, where needle syringe system were used, the advantage of needle free injection is expected to thus boost the market. The growing demand for vaccines and other products is expected to be a major factor for the growth of needle free injection system market during the forecast period. In 2018, according to World Health Organization (WHO), 86% of the infants, globally, were vaccinated for over 30 diseases, although, 20 million children remained unvaccinated. Thus, the demand for vaccines is expected to boost the growth of needle free injection systems market during the forecast period. Growing research on biologics is expected to propel the growth for the market. Biologicals are prescribed and launched for the treatment of diseases such as ulcerative colitis, Crohn’s disease, multiple sclerosis, Alzheimer’s disease, cancer, and others. Owing to these factors the needle free injection system market is expected to propel during the forecast period.

Regional Acumens:

The needle free injection systems market is expected to be dominated by North America due to high occurrence of chronic diseases such as cancer and diabetes. According to the American Cancer Society, in 2017, cancer was accounted as the second leading cause for death followed by cardiovascular diseases in the U.S. However, about 1.7 million cancer cases were accounted for the year 2016 in U.S. The increasing number of approvals for biologic drug in U.S. is expected to drive the growth for needle free injection system market during the forecast period. For instance, according to the Food and Drug Administration (FDA), in 2017, over 20 biologic formulation approvals were received from the FDA. Owing to these factors the needle free injection systems market is expected to propel during the forecast period.

Market Players:

The global players are more focused on strategies to withstand their place in the competitive market with collaborations, mergers, partnership, acquisition, and innovations. For instance, in 2017, Portal Instruments and Takeda Pharmaceutical collaborated towards the development of the needle-free drug delivery device for Crohn's diseases, hepatitis, and others. Major players for the needle free injection systems market includes Endo International plc, Antares Pharma, Inc., Zogenix, PharmaJet, Portal Instruments, Inc., Medical International Technology, Inc., Bioject Medical Technologies Inc., INJEX Pharma AG, PenJet Corporation, and Valeritas, Inc. among others.

 

Our Research Approach Includes
  •  Market Outlining
  •  Framing discussion guide
  •  Data Validation
  • Data Analysis
  •  Re-Validation and Finalization of Data
  •  Report Insights and Publishing
Our Research Approach Includes
  •  Market Outlining
  •  Framing discussion guide
  •  Data Validation
  • Data Analysis
  •  Re-Validation and Finalization of Data
  •  Report Insights and Publishing
Reach Out to us